Literature DB >> 23730631

The clinical and biochemical parameters in relation to the serum neopterin levels in Indian children and adolescents.

Srinivasa Nageswara Rao G1, Prema Gurumurthy, Sruti E, K M Cherian.   

Abstract

INTRODUCTION: An adverse pattern of blood lipids and cardiovascular abnormalities starts in obese children during childhood and neopterin serves as a marker for cardiovascular disease. Unfortunately, the data for children and adolescents, particularly, in the Indian population, are scarce. The present study aimed at evaluating the levels of serum neopterin in obese and overweight children and adolescents of the Indian population.
METHODS: The study groups included 296 school going children and adolescents. (96 obese and 97 overweight subjects were compared with 103 normal controls who were aged between 10-17 years). The anthropometric variables, the lipid profile, the fasting serum glucose which was analyzed by using an autoanalyzer and the serum neopterin levels were assayed by HPLC (Shimazdu) by using the method of Palfrey et al., 1993. The serum insulin levels were measured by using ELISA kits.
RESULTS: The serum neopterin levels (nmol/l) were elevated significantly in the obese (7.4±1.4) and overweight (6.4±0.8) (p<0.001) children and adolescents than in the controls (4.9±0.9). The serum neopterin levels showed a positive correlation with the BMI (r=0.79), WHR (r=0.5), systolic (r=0.44) and diastolic blood pressures (r= 0.25), insulin (r=0.57), HOMAIR (r=0.55), total cholesterol (r=0.35), triglycerides (r=0.20) and LDL-C (r=0.27) and they showed a negative correlation with HDL-C (r=-0.15) and fasting glucose (r= -0.3).
CONCLUSION: This study revealed a good relationship between serum neopterin and the anthropometric and biochemical parameters. We, therefore, aim to conduct regular camps at schools to counsel and advise the identified overweight and obese children to go for physical exercise and a balanced diet. The implementation of preventive measures from early childhood will have far reaching benefits, as even the prevalence of other obesity related disorders could decline.

Entities:  

Keywords:  Children; HPLC; Neopterin; Obesity

Year:  2013        PMID: 23730631      PMCID: PMC3644429          DOI: 10.7860/JCDR/2013/5128.2866

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  21 in total

1.  Prognostic value of neopterin levels in treated patients with hypertension and chest pain but without obstructive coronary artery disease.

Authors:  Pablo Avanzas; Ramón Arroyo-Espliguero; Juan Cosin-Sales; Juan Quiles; Emmanouil Zouridakis; Juan Carlos Kaski
Journal:  Am J Cardiol       Date:  2004-03-01       Impact factor: 2.778

2.  Association between insulin resistance, body mass and neopterin concentrations.

Authors:  M Ledochowski; C Murr; B Widner; D Fuchs
Journal:  Clin Chim Acta       Date:  1999-04       Impact factor: 3.786

3.  Surrogate markers of insulin resistance: A review.

Authors:  Bhawna Singh; Alpana Saxena
Journal:  World J Diabetes       Date:  2010-05-15

4.  Peroxynitrite is a major contributor to cytokine-induced myocardial contractile failure.

Authors:  P Ferdinandy; H Danial; I Ambrus; R A Rothery; R Schulz
Journal:  Circ Res       Date:  2000-08-04       Impact factor: 17.367

5.  Serum neopterin, beta2-microglobulin, soluble interleukin-2 receptors, and immunoglobulin levels in healthy adolescents.

Authors:  T Satoh; L M Brown; W A Blattner; E M Maloney; C C Kurman; D L Nelson; D Fuchs; H Wachter; D J Tollerud
Journal:  Clin Immunol Immunopathol       Date:  1998-08

Review 6.  Potential role of immune system activation-associated production of neopterin derivatives in humans.

Authors:  G Hoffmann; B Wirleitner; D Fuchs
Journal:  Inflamm Res       Date:  2003-08       Impact factor: 4.575

7.  Neopterin predicts the risk for fatal ischemic heart disease in type 2 diabetes mellitus: long-term follow-up of the HUNT 1 study.

Authors:  Inga Thorsen Vengen; Ane Cecilie Dale; Rune Wiseth; Kristian Midthjell; Vibeke Videm
Journal:  Atherosclerosis       Date:  2009-04-11       Impact factor: 5.162

8.  Association between serum neopterin, obesity and daytime sleepiness in patients with obstructive sleep apnea.

Authors:  Ahmet Ursavaş; Mehmet Karadag; Arzu Yilmaztepe Oral; Ezgi Demirdogen; Haluk Barbaros Oral; Ercüment Ege
Journal:  Respir Med       Date:  2008-06-24       Impact factor: 3.415

Review 9.  Potential to inhibit growth of atherosclerotic plaque development through modulation of macrophage neopterin/7,8-dihydroneopterin synthesis.

Authors:  S P Gieseg; E M Crone; E A Flavall; Z Amit
Journal:  Br J Pharmacol       Date:  2007-08-13       Impact factor: 8.739

10.  Increased concentrations of neopterin in carotid atherosclerosis.

Authors:  G Weiss; J Willeit; S Kiechl; D Fuchs; E Jarosch; F Oberhollenzer; G Reibnegger; G P Tilz; F Gerstenbrand; H Wachter
Journal:  Atherosclerosis       Date:  1994-04       Impact factor: 5.162

View more
  1 in total

1.  Crucial markers showing the risk of coronary artery disease in obesity: ADMA and neopterin.

Authors:  Emre Avci; Alpaslan Karabulut; Avci Gulcin Alp; Burcu Baba; Cumhur Bilgi
Journal:  J Med Biochem       Date:  2020-10-02       Impact factor: 3.402

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.